XML 29 R5.htm IDEA: XBRL DOCUMENT
v3.25.2

Consolidated Statements of Changes in Shareholders’ Equity/(Deficit) - USD ($) | Number of shares | Share capital | Warrants Reserve | Reserves | Accumulated Deficit | Total
--- | --- | --- | --- | --- | --- | ---
Balance at Mar. 31, 2022 |  | $ 4,537,055 |  | $ 255,188 | $ (3,093,543) | $ 1,698,700
Balance (in Shares) at Mar. 31, 2022 |  |  |  |  |  |
Psyence Group Inc contribution |  | 1,397,086 |  |  |  | 1,397,086
Net profit (loss) for the year |  |  |  |  | (3,206,403) | (3,206,403)
Other comprehensive income (loss) |  |  |  | (89,828) |  | (89,828)
Balance at Mar. 31, 2023 |  | 5,934,141 |  | 165,360 | (6,299,946) | (200,445)
Balance (in Shares) at Mar. 31, 2023 |  |  |  |  |  |
Issuance of shares to Psyence Group Inc |  |  |  |  |  |
Issuance of shares to Psyence Group Inc (in Shares) | 8,365 |  |  |  |  |
Issuance of shares to NCAC shareholders |  | 37,336,416 |  |  |  | 37,336,416
Issuance of shares to NCAC shareholders (in Shares) | 13,040 |  |  |  |  |
Issuance of shares for debt settlement |  | 718,500 |  |  |  | 718,500
Issuance of shares for debt settlement (in Shares) | 251 |  |  |  |  |
Issuance of shares to third party advisors |  | 2,136,340 |  |  |  | 2,136,340
Issuance of shares to third party advisors (in Shares) | 746 |  |  |  |  |
Net profit (loss) for the year |  |  |  |  | (51,159,048) | (51,159,048)
Other comprehensive income (loss) |  |  |  | 195,697 |  | 195,697
Balance at Mar. 31, 2024 |  | 46,125,397 |  | 361,057 | (57,458,994) | (10,972,540)
Balance (in Shares) at Mar. 31, 2024 | 22,402 |  |  |  |  |
Issuance of shares to third party advisors |  | $ 241,379 |  |  |  | 241,379
Issuance of shares to third party advisors (in Shares) | 586 | 586 |  |  |  |
Issuance of shares for convertible note |  | $ 4,617,286 |  |  |  | 4,617,286
Issuance of shares for convertible note (in Shares) | 38,156 | 38,156 |  |  |  |
Issuance of warrants |  |  | 682,482 |  |  | 682,482
Issuance of shares for ELOC, net of issuance costs |  | 6,410,395 |  |  |  | 6,410,395
Issuance of shares for ELOC, net of issuance costs (in Shares) | 222,292 |  |  |  |  |
Issuance of shares for warrant exchange |  | $ 192,060 |  |  |  | 192,060
Issuance of shares for warrant exchange (in Shares) | 1,104 | 1,104 |  |  |  |
Issuance of shares for promissory notes |  | $ 2,084,927 |  |  |  | 2,084,927
Issuance of shares for promissory notes (in Shares) | 99,540 |  |  |  |  |
Issuance of shares for Psyence Labs Ltd shares |  | $ 722,033 |  |  |  | 722,033
Issuance of shares for Psyence Labs Ltd shares (in Shares) | 35,594 | 35,594 |  |  |  |
Issuance of units for PIPE financing, net of issuance costs |  | $ 273,179 | 1,468,872 |  |  | 1,742,051
Issuance of units for PIPE financing, net of issuance costs (in Shares) | 47,679 | 47,679 |  |  |  |
Issuance of shares for warrant conversion |  | $ 1,085,649 | (1,085,649) |  |  |
Issuance of shares for warrant conversion (in Shares) | 100,668 |  |  |  |  |
Net profit (loss) for the year |  |  |  |  | 1,011,790 | 1,011,790
Other comprehensive income (loss) |  |  |  | (9,859) |  | (9,859)
Balance at Mar. 31, 2025 |  | $ 61,752,305 | $ 1,065,705 | $ 351,198 | $ (56,447,204) | $ 6,722,004
Balance (in Shares) at Mar. 31, 2025 | 568,021 |  |  |  |  |

X
- Definition The amount of residual interest in the assets of the entity after deducting all its liabilities. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2024-01-01 -Paragraph 24 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_a&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2024-01-01 -Paragraph 32 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_i&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2024-01-01 -Paragraph 93 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_a&doctype=Standard -URIDate 2024-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2024-01-01 -Paragraph 93 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_e&doctype=Standard -URIDate 2024-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2024-01-01 -Paragraph 93 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_b&doctype=Standard -URIDate 2024-03-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard -URIDate 2024-03-27 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 78 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_Equity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The increase (decrease) in equity resulting from the exercise of warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The increase in equity through other contributions by owners that the entity does not separately disclose in the same statement or note. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 106 -Subparagraph d -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_iii&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The increase in equity through the issue of equity instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 106 -Subparagraph d -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_iii&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_IssueOfEquity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 79 -Subparagraph a -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_iv&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfSharesOutstanding
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph IG6 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_IG6&doctype=Implementation%20Guidance -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 82A -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82A&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 18 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_18_b&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2024-01-01 -Paragraph 32 -Subparagraph a -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_ii&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2024-01-01 -Paragraph 24 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_b&doctype=Standard -URIDate 2024-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 28 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard -URIDate 2024-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard -URIDate 2024-03-27 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 12 -IssueDate 2024-01-01 -Paragraph B10 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B -URIDate 2024-03-27 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 17 -IssueDate 2024-01-01 -Paragraph 113 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_113_b&doctype=Standard -URIDate 2024-03-27 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 81A -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_a&doctype=Standard -URIDate 2024-03-27 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 106 -Subparagraph d -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_i&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ProfitLoss
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of shares issuance of units for PIPE financing, net of issuance costs. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodShareIssuanceOfUnitsForPIPEFinancingNetOfIssuanceCostsinShares
Namespace Prefix: | pbm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares Issuance of shares for convertible note. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodSharesIssuanceOfSharesForConvertibleNoteinShares
Namespace Prefix: | pbm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition NUmber of issuance of shares for debt settlement. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodSharesIssuanceOfSharesForDebtSettlement
Namespace Prefix: | pbm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issuance of shares for ELOC, net of issuance costs. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodSharesIssuanceOfSharesForELOCNetOfIssuanceCostsinShares
Namespace Prefix: | pbm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issuance of shares for promissory notes. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodSharesIssuanceOfSharesForPromissoryNotesinShares
Namespace Prefix: | pbm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issuance of shares for psyence labs ltd shares. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodSharesIssuanceOfSharesForPsyenceLabsLtdSharesinShares
Namespace Prefix: | pbm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issuance of shares for warrant conversion. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodSharesIssuanceOfSharesForWarrantConversioninShares
Namespace Prefix: | pbm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issuance of shares for warrant exchange. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodSharesIssuanceOfSharesForWarrantExchangeinShares
Namespace Prefix: | pbm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition NUmber of issuance of shares to NCAC shareholders. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodSharesIssuanceOfSharesToNCACShareholders
Namespace Prefix: | pbm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition NUmber of issuance of shares to Psyence Group Inc. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodSharesIssuanceOfSharesToPsyenceGroupInc
Namespace Prefix: | pbm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of issuance of shares to third party advisors. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodSharesIssuanceOfSharesToThirdPartyAdvisors
Namespace Prefix: | pbm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represent the amaount of issuance of shares for convertible note. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodValueIssuanceOfSharesForConvertibleNote
Namespace Prefix: | pbm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Value of issuance of shares for debt settlement. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodValueIssuanceOfSharesForDebtSettlement
Namespace Prefix: | pbm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represent the amount of issuance of shares for ELOC, net of issuance costs. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodValueIssuanceOfSharesForELOCNetOfIssuanceCosts
Namespace Prefix: | pbm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represent the amount of issuance of shares for promissory notes. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodValueIssuanceOfSharesForPromissoryNotes
Namespace Prefix: | pbm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represent the amount of issuance of shares for Psyence Labs Ltd shares. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodValueIssuanceOfSharesForPsyenceLabsLtdShares
Namespace Prefix: | pbm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represent the amount of issuance of shares for warrant conversion. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodValueIssuanceOfSharesForWarrantConversion
Namespace Prefix: | pbm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represent the amount of issuance of shares for warrant exchange. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodValueIssuanceOfSharesForWarrantExchange
Namespace Prefix: | pbm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Value of issuance of shares to NCAC shareholders. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodValueIssuanceOfSharesToNCACShareholders
Namespace Prefix: | pbm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Value of issuance of shares to third party advisors. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodValueIssuanceOfSharesToThirdPartyAdvisors
Namespace Prefix: | pbm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represent the amount of issuance of units for PIPE financing, net of issuance costs. + References No definition available. + Details
Name: | pbm_StockIssuedDuringPeriodValueIssuanceOfUnitsForPIPEFinancingNetOfIssuanceCosts
Namespace Prefix: | pbm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration